In vitro evaluation of antifungal drug combinations against Sarocladium (Acremonium) kiliense, an opportunistic emergent fungus resistant to antifungal therapies.
作者信息
Fernández-Silva Fabiola, Capilla Javier, Mayayo Emilio, Sutton Deanna, Guarro Josep
机构信息
Unitat d'Anatomia Patològica, IISPV, Universitat Rovira i Virgili, Reus, Spain.
出版信息
Antimicrob Agents Chemother. 2014;58(2):1259-60. doi: 10.1128/AAC.02131-13. Epub 2013 Nov 18.
Abstract
摘要
相似文献
1
In vitro evaluation of antifungal drug combinations against Sarocladium (Acremonium) kiliense, an opportunistic emergent fungus resistant to antifungal therapies.针对克氏帚梗柱孢霉（枝顶孢霉）的抗真菌药物组合的体外评估，克氏帚梗柱孢霉是一种对抗真菌治疗产生耐药性的机会性新出现真菌。
Antimicrob Agents Chemother. 2014;58(2):1259-60. doi: 10.1128/AAC.02131-13. Epub 2013 Nov 18.
2
Evaluation of the efficacies of Amphotericin B, Posaconazole, Voriconazole, and Anidulafungin in a murine disseminated infection by the emerging opportunistic Fungus Sarocladium (Acremonium) kiliense.评价新型机会性真菌申克孢子丝菌（枝顶孢）在小鼠播散性感染中两性霉素 B、泊沙康唑、伏立康唑和阿尼芬净的疗效。
Antimicrob Agents Chemother. 2013 Dec;57(12):6265-9. doi: 10.1128/AAC.01484-13. Epub 2013 Oct 7.
3
In vitro evaluation of the type of interaction obtained by the combination of terbinafine and itraconazole, voriconazole, or amphotericin B against dematiaceous molds.体外评价特比萘芬与伊曲康唑、伏立康唑或两性霉素 B 联合使用对暗色真菌的相互作用类型。
Antimicrob Agents Chemother. 2011 Sep;55(9):4485-7. doi: 10.1128/AAC.01015-10. Epub 2011 Jun 20.
4
In vitro interactions of licensed and novel antifungal drugs against Fusarium spp.已获许可的抗真菌药物与新型抗真菌药物对镰刀菌属的体外相互作用
Diagn Microbiol Infect Dis. 2004 Jan;48(1):69-71. doi: 10.1016/j.diagmicrobio.2003.09.003.
5
The activity of echinocandins, amphotericin B and voriconazole against fluconazole-susceptible and fluconazole-resistant Brazilian Candida glabrata isolates.棘白菌素类、两性霉素 B 和伏立康唑对氟康唑敏感和氟康唑耐药巴西光滑念珠菌分离株的活性。
Mem Inst Oswaldo Cruz. 2012 May;107(3):433-6. doi: 10.1590/s0074-02762012000300022.
6
Scopulariopsis brevicaulis, a fungal pathogen resistant to broad-spectrum antifungal agents.短帚霉，一种对广谱抗真菌剂耐药的真菌病原体。
Antimicrob Agents Chemother. 2003 Jul;47(7):2339-41. doi: 10.1128/AAC.47.7.2339-2341.2003.
7
Amphotericin B- and voriconazole-echinocandin combinations against Aspergillus spp.: Effect of serum on inhibitory and fungicidal interactions.两性霉素 B 和伏立康唑与棘白菌素联合治疗曲霉菌属：血清对抑制和杀菌相互作用的影响。
Antimicrob Agents Chemother. 2013 Oct;57(10):4656-63. doi: 10.1128/AAC.00597-13. Epub 2013 Jul 15.
8
Acremonium sclerotigenum-Acremonium egyptiacum: a multi-resistant fungal pathogen complicating the course of aplastic anaemia.棘孢木霉-埃及棘孢霉：一种多耐药性真菌病原体，使再生障碍性贫血的病程复杂化。
Clin Microbiol Infect. 2014 Jan;20(1):O30-2. doi: 10.1111/1469-0691.12319. Epub 2013 Aug 30.
9
Generation of mutants in Candida albicans with reduced susceptibility to caspofungin: influence on other antifungal products.白色念珠菌中对卡泊芬净敏感性降低的突变体的产生：对其他抗真菌药物的影响。
J Chemother. 2010 Aug;22(4):283-4. doi: 10.1179/joc.2010.22.4.283.
10
In vitro activities of 10 combinations of antifungal agents against the multiresistant pathogen Scopulariopsis brevicaulis.10种抗真菌药物组合对多重耐药病原体短帚霉的体外活性
Antimicrob Agents Chemother. 2006 Jun;50(6):2248-50. doi: 10.1128/AAC.00162-06.
引用本文的文献
1
Survival of Icelandic airborne microbes towards simulated atmospheric stress factors.冰岛气载微生物对模拟大气应激因素的生存能力。
Extremophiles. 2023 Jul 7;27(2):17. doi: 10.1007/s00792-023-01302-6.
2
Physiological Properties of Three Pelagic Fungi Isolated from the Atlantic Ocean.从大西洋分离出的三种海洋真菌的生理特性
J Fungi (Basel). 2023 Apr 4;9(4):439. doi: 10.3390/jof9040439.
3
Comparison of Atmospheric and Lithospheric Culturable Bacterial Communities from Two Dissimilar Active Volcanic Sites, Surtsey Island and Fimmvörðuháls Mountain in Iceland.冰岛叙尔特塞岛和菲姆弗鲁豪尔斯山两个不同活火山地区大气和岩石圈可培养细菌群落的比较
Microorganisms. 2023 Mar 6;11(3):665. doi: 10.3390/microorganisms11030665.
4
Fatal disseminated infection due to in a diabetic patient with COVID-19.一名新冠肺炎糖尿病患者因[具体病因未给出]导致的致命性播散性感染。
Clin Case Rep. 2021 Sep 27;9(9):e04596. doi: 10.1002/ccr3.4596. eCollection 2021 Sep.
5
Cork Oak Endophytic Fungi as Potential Biocontrol Agents against and .栓皮栎内生真菌作为对抗……和……的潜在生物防治剂
J Fungi (Basel). 2020 Nov 14;6(4):287. doi: 10.3390/jof6040287.
本文引用的文献
1
Evaluation of the efficacies of Amphotericin B, Posaconazole, Voriconazole, and Anidulafungin in a murine disseminated infection by the emerging opportunistic Fungus Sarocladium (Acremonium) kiliense.评价新型机会性真菌申克孢子丝菌（枝顶孢）在小鼠播散性感染中两性霉素 B、泊沙康唑、伏立康唑和阿尼芬净的疗效。
Antimicrob Agents Chemother. 2013 Dec;57(12):6265-9. doi: 10.1128/AAC.01484-13. Epub 2013 Oct 7.
2
Combined therapy of voriconazole and anidulafungin in murine infections by Aspergillus flavus.伏立康唑和安尼卡宾联合治疗黄曲霉感染的小鼠感染。
Mycopathologia. 2012 Apr;173(4):251-7. doi: 10.1007/s11046-011-9507-6. Epub 2011 Dec 4.
3
Acremonium phylogenetic overview and revision of Gliomastix, Sarocladium, and Trichothecium.节菱孢菌的系统发育概述以及Gliomastix、Sarocladium 和 Trichothecium 的修订。
Stud Mycol. 2011;68:139-62. doi: 10.3114/sim.2011.68.06.
4
Acremonium kiliense: reappraisal of its clinical significance.希木龙芽枝孢菌：再评价其临床意义。
J Clin Microbiol. 2011 Jun;49(6):2342-7. doi: 10.1128/JCM.02278-10. Epub 2011 Mar 30.
5
Spectrum of clinically relevant Acremonium species in the United States.美国临床相关枝顶孢属菌种的分布情况。
J Clin Microbiol. 2011 Jan;49(1):243-56. doi: 10.1128/JCM.00793-10. Epub 2010 Nov 10.
6
Combined activity in vitro of caspofungin, amphotericin B, and azole agents against itraconazole-resistant clinical isolates of Aspergillus fumigatus.卡泊芬净、两性霉素B和唑类药物对耐伊曲康唑烟曲霉临床分离株的体外联合活性。
Antimicrob Agents Chemother. 2005 Mar;49(3):1232-5. doi: 10.1128/AAC.49.3.1232-1235.2005.
7
In vitro evaluation of double and triple combinations of antifungal drugs against Aspergillus fumigatus and Aspergillus terreus.抗真菌药物双重及三联组合对烟曲霉和土曲霉的体外评价
Antimicrob Agents Chemother. 2004 Mar;48(3):970-8. doi: 10.1128/AAC.48.3.970-978.2004.
8
Successful treatment of Acremonium fungemia with voriconazole.伏立康唑成功治疗枝顶孢属真菌血症。
Mycoses. 2003 Dec;46(11-12):511-4. doi: 10.1046/j.0933-7407.2003.00924.x.
9
Genetic diversity among clinical isolates of Acremonium strictum determined during an investigation of a fatal mycosis.在一次致命真菌病调查中确定的绳状枝顶孢临床分离株之间的遗传多样性。
J Clin Microbiol. 2003 Jun;41(6):2623-8. doi: 10.1128/JCM.41.6.2623-2628.2003.
10
In vitro synergy of caspofungin and itraconazole against Aspergillus spp.: MIC versus minimal effective concentration end points.卡泊芬净与伊曲康唑对曲霉属的体外协同作用：最低抑菌浓度与最低有效浓度终点
Antimicrob Agents Chemother. 2003 Apr;47(4):1416-8. doi: 10.1128/AAC.47.4.1416-1418.2003.
Zotero 插件